Catalent
CTLT
#1796
Rank
NZ$20.97 B
Marketcap
NZ$115.53
Share price
0.00%
Change (1 day)
17.10%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): NZ-$10.40

According to Catalent's latest financial reports the company's current EPS (TTM) is NZ-$11.52. In 2023 the company made an earnings per share (EPS) of NZ-$12.38 a decrease over its 2022 EPS that were of NZ$4.13.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$10.40-15.99%
2023NZ-$12.38-399.56%
2022NZ$4.13-30.58%
2021NZ$5.9579.67%
2020NZ$3.31114.12%
2019NZ$1.55-15%
2018NZ$1.8275.44%
2017NZ$1.04-22.97%
2016NZ$1.35-59.56%
2015NZ$3.33282.05%
2014NZ$0.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
NZ-$1.38-87.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
NZ$6.61-157.35%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
NZ-$1.37-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
NZ-$2.69-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA